All In MedTech

Device Trial Radar · NCT07856082

Opt-IVF for Personalized Medicine for Normal Responders

The Advanced Decision Support Tool, Opt-IVF for Personalized Medicine for IVF Antagonist and Progesterone-Primed Ovarian Stimulation (PPOS) Protocol for Normal Responders

Last checked: Nov 20, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingRandomized with 100 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

100

Planned (sponsor's estimate)

Start

Oct 15, 2026

Primary completion

Mar 31, 2027

Study completion Apr 30, 2027

Sponsor

Lead sponsor
Urmila DIwekarNot on our public-company list
Sponsor type
Industry
First posted
Oct 2, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
Female only, from 20 years, up to 50 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A clinical trial will determine the effectiveness of the Opt-IVF decision-support tool in generating personalized, optimal drug-dosage profiles for each patient in the United States.

Conditions

  • Ivf

Interventions

  • Opt-IVFDevice

    Opt-IVF predicted dosage for IVF

  • controlOther

    Doctor prescribed dosage

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Total Gonadotropin dosageTime frame: 11 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • ABC IVF

    West Palm Beach, Florida

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.